Medication matters dominated the Aug. 18 meeting of the Kentucky Horse Racing Commission, which voted to change the descriptions for the drug classification schedules that are used to determine if a violation has occurred.
The Association of Racing Commissioners International's board of directors has unanimously approved a drug reclassification of stanozolol, boldenone, nandrolone, and testosterone, moving the anabolic steroids to Class 3 from Class 4.
A 45-day public comment period started March 2 on a series of rule amendments and additions under consideration by the California Horse Racing Board revising classification of drug substances and penalties for medication violations.
The California Horse Racing Board Medication Committee will consider major changes to the state's medication rules and penalties during a meeting Jan. 9 at Santa Anita Park.
Most Popular Stories
- Seeking the Gold Dies at 31
- Champion Tepin Will Bypass Fourstardave
- Little Mike Retired to Old Friends
- Borell Arraignment Set for Aug. 1
- American Cleopatra Entered at Del Mar
- Full Field Possible for West Virginia Derby
- Will Frankel's Success Boost F-T Yearlings?
- Nyquist, Exaggerator Renew Rivalry in Haskell
- Sunday Silence Dominates Broodmare Sires
- Reinstatement of PA Awards Payments Tabled